(Q40120516)

English

Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

toll-like receptor

0 references

author name string

Dev Karan

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Arthur M Krieg

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

David M Lubaroff

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

121

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1520-1528

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.22873

21 January 2018

Identifiers

10.1002/IJC.22873

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40120516&oldid=1886134234"